H.R. 10857 · 119th Congress
To amend the Federal Food, Drug, and Cosmetic Act and Public Health Service Act to advance the next-generation of clinical development of novel treatments and cures, and for other purposes.
- Stage
- In committee
- Sponsor
- Jake Auchincloss
- Introduced
- 2026-10-22
- Latest action
- 2026-10-22 · Introduced in House